Advisornet Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Advisornet Financial's PPH Position: Q1 2026 in Review
Advisornet Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 192 shares — an estimated $19.8K sold.
Advisornet Financial first reported a position in PPH in Q2 2020 and held it in 19 quarters. The position peaked at $50K in Q2 2020. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Advisornet Financial reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
- Advisornet Financial sold 192 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $19.8K.
- Advisornet Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and held it in 19 quarters.
- Advisornet Financial's VanEck Pharmaceutical ETF position peaked at $50K in Q2 2020.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.